Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: A Bayesian approach

Breast Cancer

Volumn 12, Issue 3, 2005, Pages 203-210

  Okamoto, Takahiro ^a   Yamazaki, Kiyomi ^a   Kanbe, Masako ^a   Kodama, Hitomi ^a   Omi, Yoko ^a   Kawamata, Akiko ^a   Suzuki, Rumi ^a   Igari, Yuka ^a   Tanaka, Reiko ^a   Lihara, Masatoshi ^a   Ito, Yukio ^a   Sawada, Tatsuo ^a   Nishikawa, Toshio ^a   Maki, Masako ^a   Kusakabe, Kiyoko ^a   Mitsuhashi, Norio ^a   Obara, Takao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Bayesian approach; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA; BAYES THEOREM; BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYMPH NODE; LYMPH NODE METASTASIS; MASTECTOMY; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BAYES THEOREM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROBABILITY; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 27744513040     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.2325/jbcs.12.203     Document Type: Article

References (53)

1. Fisher B, Jeong JH, Anderson B, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575, 2002.
2. Lin PP, Allison DC, Wainstock J, Miller KD, Dooley WC, Friedman N, Baker RR: Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11:1536-1544, 1993. (Pubitemid 23228260)
3. Dees EC, Shulman LN, Souba WW, Smith BL: Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg 226:279-287, 1997. (Pubitemid 28070920)
4. Reger V, Beito G, Jolly PC: Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 157:501-502, 1989. (Pubitemid 19127468)
5. Noguchi M, Ohta N, Thomas M, Kitagawa H, Earashi M, Miyazaki I, Mizukami Y: A retrospective study on the clinical and biological prediction of axillary lymph node metastasis in breast cancer. Surg Today 23:573-579, 1993. (Pubitemid 23211918)
6. Ravdin PM, De Laurentiis M, Vendely T, Clark GM: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 86:1771-1775, 1994. (Pubitemid 24373452)
7. Chadha M, Chabon AB, Friedmann P, Vikram B: Predictors of axillary lymph node metastases in patients with Tl breast cancer. Cancer 73:350-353, 1994. (Pubitemid 24030613)
8. Ahlgren J, Stal O, Westman G, Arnesson L-G, and the South-East Sweden Breast Cancer Group: Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncologica 33:603-608, 1994. (Pubitemid 24345363)
9. Silverstein MJ, Gierson ED, Waisman JR, Colburn WJ, Gamagami P: Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 180:700-704, 1995.
10. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW: Incidence and predictors of axillary metastasis in Tl carcinoma of the breast. J Am Coll Surg 183:185-189, 1996. (Pubitemid 26299179)
11. De Laurentiis M, Gallo C, De Placido S, Perrone F, Pettinato G, Petrella G, Carlomagno C, Panico L, Delrio P, Bianco AR: A predictive index of axillary nodal involvement in operable breast cancer. Br J Cancer 73:1241-1247, 1996. (Pubitemid 26162340)
12. Fein D, Fowble B, Hanlon AL, Hooks MA, Hoffman JP, Sigurdson ER, Jardines LA, Eisenberg BL: Identification of women with Tl-2 breast cancer at low risk of positive axillary nodes. J Surg Oncol 65:34-39, 1997. (Pubitemid 27233054)
13. Shetty MR, Reiman Jr HM: Tumor size and axillary metastasis, correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 23:139-141, 1997. (Pubitemid 27223007)
14. Barth A, Craig PH, Silverstein MJ: Predictors of axillary lymph node metastases in patients with Tl breast carcinoma. Cancer 79:1918-1922, 1997. (Pubitemid 27200375)
15. Olivotto IA, Jackson J S H, Mates D, Andersen S, Davidson W, Bryce CJ, Ragaz J: Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer 83:948-955, 1998. (Pubitemid 28401929)
16. Gann PH, Colilla SA, Gapstur SM, Winchester DJ, Winchester DP: Factors associated with axillary lymph node metastasis from breast carcinoma. Cancer 86:1511-1519, 1999. (Pubitemid 29489785)
17. Anan K, Mitsuyama S, Tamae K, Nishihara K, Iwashita T, Abe Y, Ihara T, Toyoshima S: Axillary lymph node metastases in patients with small carcinomas of the breast: Is accurate prediction possible? Eur J Surg 166:610-615, 2000. (Pubitemid 30663776)
18. Mincey BA, Bammer T, Atkinson EJ, Perez EA: Role of axillary node dissection in patients with Tla and Tib breast cancer. Arch Surg 136:779-782, 2001. (Pubitemid 32642797)
19. Choong PL, De Silva C J S, Dawkins H J S, Sterrett GF, Robbins P, Harvey JM, Papadimitriou J, Attikiouzel Y: Predicting axillary lymph node metastases in breast carcinoma patients. Breast Cancer Res Treat 37:135-149, 1996. (Pubitemid 26030091)
20. Naguib R N G, Adams AE, Home C H W, Angus B, Smith AF, Sherbet GV, Lennard T W J: Prediction of nodal metastasis and prognosis in breast cancer: A neural model. Anticancer Res 17:2735-2742, 1997.
21. Marchevsky AM, Shah S, Patel S: Reasoning with uncertainty in pathology: Artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer patients. Mod Pathol 12:505-513, 1999. (Pubitemid 29230612)
22. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 39:456-466, 1977. (Pubitemid 8063506)
23. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992.
24. Davison SP, Clifton MS, Kauffman L, Minasian L: Sentinel node biopsy for the detection of head and neck melanoma. Ann Plast Surg 47:206-211, 2001. (Pubitemid 32729883)
25. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-339, 1993.
26. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398, 1994.
27. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996. (Pubitemid 26406231)
28. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
29. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC: Meta-analysis of sentinel node biopsy in breast cancer. J Surg Res 84:138-142, 1999. (Pubitemid 29389989)
30. Fraile M, Rull M, Julian FJ, Fuste F, Barnadas A, Llatjos M, Castella E, Gonzalez JR, Vallejos V, Alastrue A, Broggi MA: Sentinel node biopsy as a practical alternative to avoid axillary lymph node dissection in breast cancer patients: An approach to its validity. Ann Oncol 11:701-705, 2000.
31. Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, Ohta M, Kurosumi M, Tsugawa K: A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63:31-40, 2000.
32. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinelnode biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003. (Pubitemid 36951366)
33. Cantin J, Scarth H, Levine M, Hugi M, for the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ 165:166-173, 2001. (Pubitemid 32904641)
34. Krag D, Weaver D, Ashikaga T, Moffat F, Himberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 339:941-946, 1998. (Pubitemid 28455095)
35. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645-653, 1998. (Pubitemid 28530914)
36. Sobin LH, Wittekind C (Eds). TNM Classification of Malignant Tumors, 5th edition, John Wiley & Sons, New York, 1997.
37. Kleinbaum DG: Modeling strategy guidelines. In Logistic regression: A self-learning text. Kleinbaum DG, Springer-Verlag New York, pp161-190, 1994.
38. Armitage P, Berry G: Bayes' theorem. In Statistical Methods in Medical Research., Armitage P, Berry G., 3rd Ed., Blackwell, Oxford, pp71-77, 1994.
39. Noguchi M: Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer 10:179-187, 2003.
40. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ: Sentinel lymph node biopsy for breast cancer - Not yet the standard of care. N Engl J Med 339:990-995, 1998. (Pubitemid 28455104)
41. Hansen NM, Grube BJ, Giuliano AE: The time has come to change algorithm for the surgical management of early breast cancer. Arch Surg 137:1131-1135, 2002. (Pubitemid 35155246)
42. Guenther JM, Hansen NM, Di Fronzo LA, Giuliano AE, Collins JC, Grube BL, O'Connell TX: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 138:52-56, 2003. (Pubitemid 36055648)
43. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000. (Pubitemid 30056936)
44. Blanchard K, Donohue JH, Reynolds C, Grant CS: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482-488, 2003. (Pubitemid 36542459)
45. Takei H, Suemasu K, Kurosumi M, Uchida K, Igarashi K, Ninomiya J, Naganuma R, Kusawake T, Sugamata N, Matsumoto H, Higashi Y: Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer 9:344-348, 2002.
46. Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee: Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94:2542-2551, 2002. (Pubitemid 34478066)
47. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami H-O: Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421-430, 2001. (Pubitemid 32049639)
48. Singletary SE: Rating the risk factor for breast carcinoma. Ann Surg 237:474-482, 2003. (Pubitemid 38176426)
49. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL: Body mass and stage of breast cancer at diagnosis. Int J Cancer 98:279-283, 2002. (Pubitemid 34150814)
50. Honda H, Ohi Y, Umekita Y, Takasaki T, Kuriwaki K, Ohyabu I, Yoshioka T, Yoshida A, Taguchi S, Ninomiya K, Akiba S, Nomura S, Sagara Y, Yoshida H: Obesity affects expression of progesterone receptors and node metastasis of mammary carcinomas in postmenopausal women without a family history. Pathol Int 49:198-202, 1999. (Pubitemid 29210545)
51. Ryu SY, Kim CB, Nam CM, Park JK, Kim KS, Park J, Yoo Y, Cho KS: Is body mass index the prognostic factor in breast cancer? A meta-analysis. J Korean Med Set 16:610-614, 2001. (Pubitemid 33741670)
52. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL: Relation of body mass index to tumor makers and survival among young women with invasive ductal carcinoma. Cancer 92:720-729, 2001. (Pubitemid 32783055)
53. Kyogoku S, Hirohata T, Takeshita S, Nomura S, Shigematsu T, Horie A: Survival of breast-cancer patients and body size indicators. Int J Cancer 46:824-831, 1990.